- Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial. Annals of the rheumatic diseases. 2016 Academic Article GET IT
Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study.
The Lancet Respiratory Medicine.
Times cited: 1
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.
The New England journal of medicine.
Times cited: 135
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). The Lancet. 1999 Academic Article GET IT